Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Cahodes getting sued...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by visionaryfoolon Jul 29, 2016 1:57pm
161 Views
Post# 25096469

RE:RE:RE:Cahodes getting sued...

RE:RE:RE:Cahodes getting sued...Yeah agree with Lattice here... Marc... agh... I dunno know what to say anymore.

LatticeInExiIe wrote:
GoldBug024 wrote:
next up to sue him will probably be BC politicians. Maybe he's shorting his net worth?

I would thoroughly read the article, along with the open letter to the BoD. 

Charley Grant is a friend of Mark Cohodes.  This is not good for Concordia and it is laughable how you are interpreting this as good news for Thompson.  



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities